Renegade Bio

Fast Accessible Secure Triage for COVID-19

Company Details

Renegade.bio is accelerating the capacity to test novel pathogens such as COVID-19.
Renegade.bio is an agile team of science, technology, and logistics experts, mobilizing in the public interest to make fast, safe, regular coronavirus testing accessible to all—starting with healthcare workers, first responders, and other health and safety workers.

Assembled in swift response to this global emergency, and working with other CLIA-certified labs, researchers, and organizations across the ecosystem of public health, we are working day and night with a singular goal: to make COVID-19 testing accessible to everyone—because we know it will take nothing less to end this pandemic.

Our technology, the renagade XP COVID-19 testing methodology gives organizations responsible for public health and safety the ability to rapidly and cost-effectively scale up the distributed collective capacity that is urgently needed for widespread ongoing COVID-19 testing.

Renegade.bio is currently seeking partnerships with first responder organizations, hospitals and law enforcement units to expand their COVID-19 testing.

Company People

Craig Rouskey

Craig Rouskey
CEO & Co-Founder

Gabriel Paulino

Gabriel Paulino
COO and Co-Founder

Renegade Bio News

VIEW ALL

You might also be interested in

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities.